US FDA panel backs Bristol transplant drug - Reuters

[INCIID News Feed]

<img alt="" height="1" width="1" />
US FDA panel backs Bristol transplant drug
Reuters
WASHINGTON, March 1 (Reuters) - Bristol-Myers Squibb Co&#39;s (BMY.N) experimental kidney transplant drug belatacept should be approved to give doctors and patients more treatment options, but long-term data and a stringent patient registry are needed, ...
FDA panel back Bristol-Myers transplant drugSan Francisco Chronicle
FDA panel back Bristol-Myers transplant drugThe Associated Press
Bristol-Myers Transplant Drug Wins Backing by US FDA PanelBusinessWeek
Easy Bourse -Seeking Alpha (blog)
all 73 news articles &raquo;


More...